View Full Company Profile

Fortive Corp

CIK: 1659166 Filed: February 25, 2026 10-K

Key Highlights

  • Fortive reported solid FY2023 performance with $6.2 billion in revenue (4.5% increase) and $950 million in net earnings (8% increase).
  • Generated strong operating cash flow of $1.1 billion, supporting strategic investments and maintaining a healthy balance sheet with a 2.5x net debt to EBITDA ratio.
  • Actively optimized its portfolio through two tuck-in acquisitions in healthcare software and a $150 million divestiture of a non-core industrial asset.
  • Anticipates 2024 revenue growth of 3-5% and plans to invest $400 million in R&D, focusing on AI-driven analytics for workflow solutions.
  • Maintains a strong competitive position through proprietary technologies, deep customer relationships, and a focus on mission-critical applications in high-growth markets.

Financial Analysis

Fortive Corp SEC filing summary

Understanding Fortive Corp's latest annual report can be complex. We've distilled the key insights into plain English, offering retail investors a clear picture of the company's financial health, strategic direction, and what it means for your investment.

Business Overview

Fortive (FTV) is a global industrial technology innovator that delivers essential workflow solutions in attractive, high-growth markets. The company's core strategy focuses on continuously optimizing its portfolio, investing in high-margin, recurring revenue businesses, and leveraging digital capabilities to enhance customer value.

Fortive operates primarily through two segments:

  • Intelligent Operating Solutions (IOS): This segment provides precision technologies for manufacturing.
  • Advanced Healthcare Solutions (AHS): This segment offers critical tools and software for healthcare workflows.

Fortive drives growth through innovation, strategic acquisitions, and operational excellence, targeting markets with high barriers to entry and strong long-term growth trends.

Financial Performance Highlights (Fiscal Year 2023)

Fortive delivered a solid performance this fiscal year, demonstrating resilience in a dynamic economic environment.

  • Revenue Growth: The company reported total revenue of approximately $6.2 billion, a 4.5% increase from the prior year. Strong demand in the Advanced Healthcare Solutions segment and strategic price increases across the portfolio primarily drove this growth, though currency headwinds partially offset it.
  • Profitability: Net earnings reached $950 million, resulting in diluted earnings per share (EPS) of $2.65, an 8% increase year-over-year. Operating margins remained robust at 18.5%, reflecting effective cost management and a favorable product mix towards higher-value solutions.

Management's Discussion & Analysis (MD&A) Highlights

Management emphasized Fortive's strategic agility in navigating a complex economic landscape. They attributed revenue growth to strong execution in key segments and effective pricing strategies. The increase in net earnings and robust operating margins reflected disciplined cost management and a favorable shift towards higher-value solutions.

The MD&A highlighted several strategic actions:

  • Successful integration of recent acquisitions.
  • Strategic divestiture to optimize the portfolio for long-term growth and profitability.

Management also discussed the impact of currency fluctuations and supply chain dynamics on results, outlining ongoing efforts to mitigate these challenges. Strong operating cash flow generation served as a critical enabler for strategic investments in innovation and M&A, reinforcing the company's capital allocation priorities.

Segment Performance Breakdown

  • Intelligent Operating Solutions (IOS): This segment grew modestly by 2.8% to $3.8 billion. Automation trends drove strong performance in its product identification and sensing businesses. However, softer demand in certain industrial automation markets, due to broader economic caution, partially offset this growth.
  • Advanced Healthcare Solutions (AHS): AHS was a standout performer, growing 7.5% to $2.4 billion. Increased adoption of its critical care diagnostics and clinical workflow solutions, particularly in North America and Europe, fueled this growth as healthcare providers continue to invest in efficiency and patient safety.

Geographic Trends

North America remained Fortive's largest market, contributing 55% of total revenue and growing steadily by 5%. Europe experienced moderate growth of 3%. The Asia Pacific region, particularly China, presented mixed results; some areas showed strength, but ongoing macroeconomic challenges led to a flat revenue contribution.

Financial Health

Fortive generated strong operating cash flow of $1.1 billion, which enabled significant investments in R&D and strategic acquisitions. The company maintained a healthy balance sheet with total debt of $3.5 billion and a net debt to EBITDA ratio of 2.5x, demonstrating sound financial leverage. Fortive also returned $300 million to shareholders through share repurchases and maintained its quarterly dividend.

Future Outlook

Fortive continues its strategy of portfolio enhancement and innovation. The company highlighted two key actions from the second half of 2023:

  • Two tuck-in acquisitions in the healthcare software space, completed to expand recurring revenue streams and digital offerings.
  • The divestiture of a non-core industrial asset for $150 million, streamlining its focus on higher-growth, higher-margin businesses.

Looking ahead to 2024, Fortive anticipates revenue growth in the range of 3-5%. It will continue to focus on innovation, particularly in AI-driven analytics for its workflow solutions. The company expects to invest approximately $400 million in R&D to drive future product development and maintain its competitive edge.

Competitive Position

Fortive operates in highly competitive global markets, characterized by rapid technological change and a mix of large, diversified companies and smaller, specialized firms.

Fortive's competitive advantages stem from:

  • Strong brand reputation
  • Proprietary technologies
  • Extensive intellectual property portfolio
  • Deep customer relationships

The company differentiates itself by focusing on mission-critical applications, delivering high-quality, reliable, and innovative workflow solutions that often integrate hardware, software, and services. Leveraging a global sales and service network, coupled with a disciplined acquisition strategy that targets market-leading technologies, further strengthens its competitive standing.

To maintain leadership, Fortive continuously invests in research and development to enhance its product offerings and expands into adjacent high-growth markets.

Risk Factors

Several factors could impact Fortive's future performance. Investors should be aware of these potential risks:

  • Global economic slowdowns that could impact industrial demand.
  • Supply chain disruptions that could affect component availability and costs.
  • Intense competition in key markets, which requires continuous innovation.
  • The evolving regulatory landscape in healthcare.
  • Geopolitical instability.
  • Currency fluctuations.
  • The ability to successfully integrate acquisitions.

These factors pose ongoing risks to financial results.

Conclusion

Fortive's latest annual report reveals a financially sound company executing a focused strategy. With solid revenue growth, strong profitability, and a healthy balance sheet, Fortive is well-positioned to navigate future challenges and capitalize on opportunities in precision technologies and critical workflow solutions. Key drivers for sustained growth include its innovation pipeline and the successful integration of recent acquisitions. This summary provides the essential information to help you evaluate Fortive as a potential investment.

Risk Factors

  • Global economic slowdowns could impact industrial demand.
  • Supply chain disruptions may affect component availability and costs.
  • Intense competition in key markets requires continuous innovation.
  • The evolving regulatory landscape in healthcare poses challenges.
  • Geopolitical instability, currency fluctuations, and the ability to integrate acquisitions successfully are ongoing risks.

Why This Matters

This annual report provides crucial insights for investors by showcasing Fortive's resilience and strategic execution in a dynamic economic environment. The reported 4.5% revenue growth and 8% increase in net earnings, coupled with robust operating margins, signal a financially healthy company capable of navigating market complexities. For investors, this demonstrates Fortive's ability to generate value and maintain profitability, making it an attractive prospect for those seeking stable growth.

Furthermore, the report highlights Fortive's commitment to portfolio optimization through strategic acquisitions in high-growth areas like healthcare software and the divestiture of non-core assets. This proactive approach to managing its business segments suggests a forward-thinking management team focused on long-term value creation. The strong operating cash flow generation also underscores the company's capacity to fund future innovation and M&A, which are critical for sustaining competitive advantage and expanding market reach.

The clear future outlook, including an anticipated 3-5% revenue growth for 2024 and significant R&D investment in AI-driven analytics, provides transparency and confidence. Investors can appreciate a company that not only performs well but also clearly articulates its strategic direction and investment priorities. This comprehensive view allows investors to assess Fortive's potential for continued growth and its ability to adapt to technological advancements and market demands.

Financial Metrics

Total Revenue ( F Y2023) $6.2 billion
Revenue Growth ( Yo Y) 4.5%
Net Earnings ( F Y2023) $950 million
Diluted E P S ( F Y2023) $2.65
E P S Growth ( Yo Y) 8%
Operating Margins 18.5%
I O S Segment Revenue ( F Y2023) $3.8 billion
I O S Segment Growth ( Yo Y) 2.8%
A H S Segment Revenue ( F Y2023) $2.4 billion
A H S Segment Growth ( Yo Y) 7.5%
North America Revenue Contribution 55%
North America Growth ( Yo Y) 5%
Europe Growth ( Yo Y) 3%
Operating Cash Flow ( F Y2023) $1.1 billion
Total Debt ( F Y2023) $3.5 billion
Net Debt to E B I T D A Ratio 2.5x
Shareholder Returns ( F Y2023) $300 million
Divestiture Value ( H2 2023) $150 million
Revenue Growth Outlook (2024) 3-5%
R& D Investment Outlook (2024) $400 million

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

February 26, 2026 at 01:29 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.